NCT05561868View on ClinicalTrials.gov

COVID-19 Antibody Responses in Cystic Fibrosis

Active, not recruitingOBSERVATIONAL
Enrollment

70

Participants

Timeline

Start Date

August 22, 2022

Primary Completion Date

September 1, 2025

Study Completion Date

September 1, 2025

Conditions
Cystic FibrosisCOVID-19
Trial Locations (2)

D24 TN3C

Children's Health Ireland at Tallaght, Tallaght

D12 N512

Children's Health Ireland at Crumlin, Dublin

All Listed Sponsors
collaborator

European Cystic Fibrosis Society

UNKNOWN

collaborator

Cystic Fibrosis Foundation

OTHER

collaborator

Queen's University, Belfast

OTHER

lead

Children's Health Ireland

OTHER_GOV